Ironwood Financial’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2
Closed 324
2021
Q3
$0 Hold
2
﹤0.01% 581
2021
Q2
$0 Hold
2
﹤0.01% 569
2021
Q1
$0 Hold
2
﹤0.01% 549
2020
Q4
$0 Hold
2
﹤0.01% 493
2020
Q3
$0 Hold
2
﹤0.01% 442
2020
Q2
$0 Hold
2
﹤0.01% 415
2020
Q1
$0 Hold
2
﹤0.01% 370
2019
Q4
$0 Hold
2
﹤0.01% 382
2019
Q3
$0 Hold
2
﹤0.01% 386
2019
Q2
$0 Hold
2
﹤0.01% 379
2019
Q1
$0 Hold
2
﹤0.01% 374
2018
Q4
$0 Hold
2
﹤0.01% 372
2018
Q3
$0 Hold
2
﹤0.01% 363
2018
Q2
$6K Hold
2
﹤0.01% 224
2018
Q1
$6K Hold
2
0.01% 197
2017
Q4
$5K Hold
2
﹤0.01% 209
2017
Q3
$4K Hold
2
﹤0.01% 225
2017
Q2
$2K Hold
2
﹤0.01% 240
2017
Q1
$3K Hold
2
﹤0.01% 228
2016
Q4
$4K Hold
2
﹤0.01% 217
2016
Q3
$5K Hold
2
﹤0.01% 204
2016
Q2
$5K Hold
2
﹤0.01% 204
2016
Q1
$8K Buy
+2
New +$6.95K 0.01% 178
2015
Q3
$3K Hold
2
﹤0.01% 308
2015
Q2
$18K Hold
2
0.01% 170
2015
Q1
$22K Hold
2
0.01% 153
2014
Q4
$18K Buy
+2
New +$15.4K 0.01% 143

Other funds holding IMUX

Ironwood Financial's IMUX Position: Q4 2021 in Review

Ironwood Financial sold out of Immunic (IMUX) in Q4 2021, closing a stake of 2 shares.

Ironwood Financial first reported a position in IMUX in Q4 2014 and held it in 27 quarters. The position peaked at $22K in Q1 2015. 67 funds tracked by Wall St. Rank hold IMUX as of Q4 2021.

  • Ironwood Financial reported no remaining Immunic position as of Q4 2021 after selling out during the quarter.
  • Ironwood Financial sold 2 Immunic shares in Q4 2021.
  • Ironwood Financial first reported a position in Immunic in Q4 2014 and held it in 27 quarters.
  • Ironwood Financial's Immunic position peaked at $22K in Q1 2015.
  • 67 funds tracked by Wall St. Rank held Immunic as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.